Pelthos Therapeutics PTHS
NYSE PTHS
$20.77 +0.11 (+0.53%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) Net Equity Issued and Repurchased (2024 - 2025)

Updated

Pelthos Therapeutics' Net Equity Issued and Repurchased came in at $121,000 for Q4 2025.

Analysis

Pelthos Therapeutics (PTHS) Net Equity Issued and Repurchased (2024 - 2025) Analysis & Trends

For FY2025, Pelthos Therapeutics' Net Equity Issued and Repurchased was $206,000, down 96.6% from FY2024.

  • Going back by year, Net Equity Issued and Repurchased was $5.97 million in FY2024 and $255,412 in FY2023.
  • The Q4 2025 figure represents the highest quarterly Net Equity Issued and Repurchased since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 6.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 9.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Pelthos Therapeutics 76.83 Mn -11.57 Mn 11.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 121,000.00
Mar 31, 2024 5.97 Mn
API Access

Pelthos Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PTHS&period=max&api_key=YOUR_API_KEY